Clinical Trials on Psychiatric Pathologies in Australia

Total 2737 results

University of Melbourne
The University of Queensland; Swinburne University of Technology

Completed

Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial (KGAD)

Generalized Anxiety Disorder

Australia
Melbourne Health
William Buckland Foundation

Completed

Recovery Therapy Trial

Psychotic Disorders | Mood Disorders | Schizophrenia

Australia
Bayside Health
National Health and Medical Research Council, Australia

Recruiting

Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery (TRIGS)

Bleeding | Anesthesia | Gastrointestinal Complication | Healthcare Associated Infection | Infection Wound

Australia
Bayside Health
Monash University

Recruiting

Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial (TRIGS-D)

Dementia | Surgical Site Infection | Cognition

Australia
Medicines for Malaria Venture
GlaxoSmithKline; ICON plc; QIMR Berghofer Medical Research Institute; Swiss BioQuant... and other collaborators

Completed

Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum

Pathologic Processes | Infections | Systemic Inflammatory Response Syndrome | Inflammation | Vector Borne Diseases | Parasitic Diseases | Protozoan Infections | Malaria | Parasitemia | Malaria,Falciparum | Anti-Infective Agents | Antimalarials

Australia
Melbourne Health

Completed

Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features

Schizoaffective Disorder | Bipolar Disorder

Australia
Peter MacCallum Cancer Centre, Australia

Completed

A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer

Malignant Rectal Neoplasm | Recurrent Tumor

Australia
RDC Clinical Pty Ltd

Not yet recruiting

Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population

Joint Pain | Muscle Pain | Chronic Inflammation | Mobility

Australia
Monash University
National Health and Medical Research Council, Australia

Active, not recruiting

Statins in Reducing Events in the Elderly (STAREE) Heart Sub-study (STAREE-HEART)

Heart Failure | Atrial Fibrillation | Hypercholesterolemia | Healthy Ageing

Australia
Bayside Health

Unknown

Sympathetic Activity in Individuals With the Metabolic Syndrome: Benefits of Lifestyle Interventions

Metabolic Syndrome X

Australia
Olive Lifesciences Pvt Ltd
College of Health and Biomedicine, Victoria University

Unknown

The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome

Obesity | Metabolic Syndrome

Australia
ProVerum Medical

Completed

The ProVerum First in Man PROVE Study

Benign Prostatic Hyperplasia

Australia
Monash University

Completed

Melatonin to Prevent Brain Injury in Unborn Growth Restricted Babies

Fetal Growth Retardation

Australia
Murdoch Childrens Research Institute

Completed

Safety of Autologous Cord Blood Cells in HLHS Patients During Norwood Heart Surgery

Heart Defects, Congenital | Hypoplastic Left Heart Syndrome | Pediatric Disorder

Australia
The Alfred

Unknown

A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis (CISTIC)

Cystic Fibrosis

Australia
Oslo University Hospital
Lund University; University of Aarhus; University of Oxford; University of Ottawa; La Trobe University

Recruiting

Arthroscopic Surgical Procedures vs Sham Surgery for Patients With Femoroacetabular Impingement and/or Labral Tears. (HIPARTI)

Surgery

Australia, Norway
GlaxoSmithKline

Completed

A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers. (P1A114919)

Multiple Sclerosis, Relapsing-Remitting

Australia
Rakshit Panwar

Recruiting

Individualised Blood Pressure Targets Versus Standard Care Among Critically Ill Patients With Shock (REACT-SHOCK)

Shock | Critical Illness

Australia
Implicit Bioscience

Withdrawn

IC14 for Rapidly Progressive Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary (FAPI-CUP)

Cancer of Unknown Primary Site

Australia
Baker Heart and Diabetes Institute
The Alfred; Monash Medical Centre; Servier Laboratories (Australia) Pty Ltd

Unknown

Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

Australia
Emma Ridley

Not yet recruiting

CONTINUation of Enteral Nutrition Prior to Extubation Compared to Standard Care (CONTINUE)

Critical Illness

Australia
The University of Queensland
Telethon Kids Institute

Completed

Prevention of Bronchiectasis in Infants With Cystic Fibrosis (COMBATCF)

Bronchiectasis | Cystic Fibrosis

Australia, New Zealand
Kirby Institute

Completed

Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based Settings (SHARP-C)

Hepatitis C, Chronic

Australia
The George Institute for Global Health, Australia

Completed

Days Alive and Out of Hospital for Patients With Sepsis

Sepsis | Septic Shock

Australia
Swinburne University of Technology
National Institute of Circus Arts

Recruiting

Exercise Rehabilitation for Hip-related Pain and Dysfunction in Student Circus Arts Performers

Hip Dysplasia | Femoro Acetabular Impingement

Australia
Biogen

Terminated

How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose (TODAY)

Relapsing Remitting Multiple Sclerosis

Australia
Austin Health

Unknown

"Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery

Myocardial Ischemia | Coronary Artery Disease | Blood Coagulation Disorders | Heart Valve Diseases

Australia
Mateon Therapeutics

Completed

Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden (OXi4503)

Neoplasm Metastasis

Australia
Sydney Local Health District

Recruiting

The Use of Remote Monitoring for Orthodontic Retention Review

Orthodontic Relapse

Australia
GlaxoSmithKline

Completed

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. (ARI115707)

Prostatic Hyperplasia

Australia
Bayside Health

Unknown

Modified Release Posaconazole in Patients With Cystic Fibrosis

Cystic Fibrosis

Australia
The Alfred

Unknown

CPET in CF Patients With One G551D Mutation Taking VX770

Cystic Fibrosis

Australia
Gilead Sciences

Completed

Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male Volunteers

Cystic Fibrosis

Australia
Medicines for Malaria Venture
QIMR Berghofer Medical Research Institute; Children's Health Queensland Hospital... and other collaborators

Completed

Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malaria

Protozoan Infections | Malaria | Parasitemia | Malaria,Falciparum | Parasitic Disease | Malaria Recrudescence

Australia
Baker Heart and Diabetes Institute

Completed

Polycystic Ovary Syndrome - Improving Outcomes

Polycystic Ovary Syndrome

Australia
Professor Michael Bourke

Completed

Fully Coated, Removable, Self-expanding Oesophageal Stents for Preventing Strictures Following Complete Barretts Excision. (CBE-001-SEOS)

Constriction, Pathological

Australia
Montreal Heart Institute
Canadian Institutes of Health Research (CIHR); Johnson & Johnson; Abbott Medical...

Completed

ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination: the ADVICE Trial (ADVICE)

Paroxysmal Atrial Fibrillation | Pulmonary Vein Isolation | Dormant Pulmonary Vein Conduction

Canada, Belgium, Australia, Germany, Austria, France
Foundation for Angelman Syndrome Therapeutics,...
Queensland University of Technology

Recruiting

The Global Angelman Syndrome Registry (GASR)

Angelman Syndrome

Australia
Aptevo Therapeutics

Terminated

Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis

Psoriasis | Ulcerative Colitis

Australia
Melbourne Health
National Health and Medical Research Council, Australia; Bristol-Myers Squibb

Terminated

Impact of Tight Glycaemic Control in Acute Myocardial Infarction

Myocardial Infarct | Hyperglycemia

Australia
The University of New South Wales

Completed

Escitalopram as a Mood Stabilizer for Bipolar II Disorder

Bipolar Disorders

Australia
Innate Immunotherapeutics
Syneos Health

Completed

Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis

Secondary Progressive Multiple Sclerosis

New Zealand, Australia
Bayside Health
Deakin University

Completed

Time Interval for Changing Closed System Suction Catheters, Effect on Ventilator Associated Pneumonia

Pneumonia, Ventilator Associated | Closed System Suction Catheter

Australia
GlaxoSmithKline

Completed

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. (ARI114694)

Prostatic Hyperplasia

Australia
Murdoch Childrens Research Institute

Completed

Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction (COSI BAIR)

COVID-19 | Vaccine Reaction | Immunization; Infection

Australia
Novartis Pharmaceuticals

Completed

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Bone Neoplasms

Australia
Gilead Sciences

Completed

A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial of GS-9411 in Healthy Volunteers

Cystic Fibrosis | Mucociliary Clearance | Airway Hydration

Australia
Gilead Sciences

Completed

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male Volunteers

Cystic Fibrosis | Mucociliary Clearance | Airway Hydration

Australia

Clinical Trials on Psychiatric Pathologies in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations